Company Quick10K Filing
OWC Pharmaceutical Research
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-13
S-1 2019-05-31 Public Filing
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-16
S-1 2018-06-14 Public Filing
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-18
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-29
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-17
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-01
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-07-29
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-21
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-12
10-Q 2013-03-31 Filed 2013-05-14
10-K 2012-12-31 Filed 2013-04-15
8-K 2020-09-23
8-K 2020-09-14
8-K 2020-08-31
8-K 2020-06-25
8-K 2020-06-21
8-K 2020-03-30
8-K 2020-03-19
8-K 2020-03-12
8-K 2020-03-09
8-K 2019-12-20
8-K 2019-12-12
8-K 2019-11-13
8-K 2019-11-13
8-K 2019-10-22
8-K 2019-10-07
8-K 2019-09-16
8-K 2019-08-29
8-K 2019-07-24
8-K 2019-05-23
8-K 2019-05-06
8-K 2019-04-15
8-K 2019-04-04
8-K 2019-03-13
8-K 2019-02-22
8-K 2019-02-05
8-K 2019-02-01
8-K 2019-01-29
8-K 2018-12-31
8-K 2018-11-30
8-K 2018-11-30
8-K 2018-10-22
8-K 2018-08-21
8-K 2018-08-01
8-K 2018-06-28
8-K 2018-06-13
8-K 2018-04-30
8-K 2018-03-08
8-K 2018-03-05
8-K 2018-02-19

OWC Pharmaceutical Research Financials

OWCP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
30DC (TDCH)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
3D Total Solutions (DTLS)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash4178298471,3891,4691,166799532357266162904721,3801,1139716924,6494,2193,4642,8001,8401,465
Accounts Receivable
Inventory
PP&E26292928262318371411104633333373353331
Assets4178298471,4371,5231,1958405684303432391304972,0761,4131,2181,0617364,7744,3123,5532,9492,3351,773
Accounts Payable12173753459853640657112823198163104286
Long-Term Debt
Liabilities741021284981604056471083153512373964481762082702346,4246,76810,76710,2511,7501,467
Stockholders' Equity-57-947981,3561,4631,15478552132328-150-1071011,6271,2371,010791502-2,183-3,791-9,440-10,242-3,043-4,008
Income Statement ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000000000050000010001000
Cost of Revenue
Gross Profit
R&D0000000160997797-15373530-2443421694-782155273126285320168
SG&A59149149472-1074,3541543055333112452228475-2,3871,4011,5581,106-6,851821756543498395519
Tax0000000000
Net Income-71-170-42-35-509-4,354-315-405-408-233-314-80-141-1,658-1,435-445-1,201-1,477-977-2,990-991-1,0007,707-287
Cash Flow ($'000)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-19-49-14-9-17-22-289-274-3871,138-1,795-173-172-100-126-131-191-395-274-326-371-949-427-665-955-372
Cash Investing-6-2-2010-10-2-6-10-10-20-20
Cash Financing156354238608593539002410710505251,768-273101891054,9180000